Bayesian Capital Management »

Beam Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $291k 8.8k 33.04
2022-03-31 $464k 8.1k 57.28